Genetic variants associated with cardiac structure and function: A meta-analysis and replication of genome-wide association data

JAMA

Volumn 302, Issue 2, 2009, Pages 168-178

  Vasan, Ramachandran S ^a,b   Glazer, Nicole L ^e   Felix, Janine F ^l   Lieb, Wolfgang ^m   Wild, Philipp S ^q   Felix, Stephan B ^r,v   Watzinger, Norbert ^w   Larson, Martin G ^a,c   Smith, Nicholas L ^f,g   Dehghan, Abbas ^l   Großhennig, Anika ^m   Schillert, Arne ^m   Teumer, Alexander ^s,v   Schmidt, Reinhold ^w   Kathiresan, Sekar ^a   Lumley, Thomas ^f   Aulchenko, Yurii S ^l   König, Inke R ^m   Zeller, Tanja ^q   Homuth, Georg ^s,v   Struchalin, Maksim ^l   Aragam, Jayashri ^a   Bis, Joshua C ^e   Rivadeneira, Fernando ^l   Erdmann, Jeanette ^m   Schnabel, Renate B ^q   Dörr, Marcus ^r,v   Zweiker, Robert ^w   Lind, Lars ^x   Rodeheffer, Richard J ^z   Greiser, Karin Halina ^aa   Levy, Daniel ^a,d   Haritunians, Talin ^k   Deckers, Jaap W ^l   Stritzke, Jan ^m   Lackner, Karl J ^q   Völker, Uwe ^s,v   Ingelsson, Erik ^y   Kullo, Iftikhar ^z   Haerting, Johannes ^aa   O'Donnell, Christopher J ^a,d   Heckbert, Susan R ^f   Stricker, Bruno H ^l   Ziegler, Andreas ^m   Reffelmann, Thorsten ^r,v   Redfield, Margaret M ^z   Werdan, Karl ^a   Mitchell, Gary F ^a   Rice, Kenneth ^f   Arnett, Donna K ⁱ   Hofman, Albert ^l   Gottdiener, John S ^j   Uitterlinden, Andre G ^l   Meitinger, Thomas ^n,p   Blettner, Maria ^q   Friedrich, Nele ^u,v   Wang, Thomas J ^a   Psaty, Bruce M ^e,f,h   Van Duijn, Cornelia M ^l   Wichmann, H Erich ^n,o   Munzel, Thomas F ^q   Kroemer, Heyo K ^t,v   Benjamin, Emelia J ^a,b   Rotter, Jerome I ^k   Witteman, Jacqueline C ^l   Schunkert, Heribert ^m   Schmidt, Helena ^w   Völzke, Henry ^u,v   Blankenberg, Stefan ^q   more..

^a FRAMINGHAM HEART STUDY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Boston University   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g DEPARTMENT OF VETERANS AFFAIRS   (United States)

^h CENTER FOR HEALTH STUDIES   (United States)

ⁱ UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^j UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^k CEDARS SINAI MEDICAL CENTER   (United States)

^l ERASMUS MEDICAL CENTER   (Netherlands)

^m UNIVERSITY OF LÜBECK   (Germany)

ⁿ INSTITUTE OF EPIDEMIOLOGY   (Germany)

^o UNIVERSITY OF MUNICH   (Germany)

^p TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^q JOHANNES GUTENBERG UNIVERSITY   (Germany)

^r Interfaculty Institute for Genetics and Functional Genomics ^*

^s Interfaculty Institute for Genetics and Functional Genomics   (Germany)

^t Institute of Pharmacology

^u Institute for Community Medicine

^v UNIVERSITY OF GREIFSWALD   (Germany)

^w MEDICAL UNIVERSITY OF GRAZ   (Austria)

^x UPPSALA UNIVERSITY   (Sweden)

^y KAROLINSKA INSTITUTE   (Sweden)

^z MAYO CLINIC   (United States)

^aa MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AORTA ROOT; ARTICLE; CARDIOVASCULAR DISEASE; CHROMOSOME 12P; CHROMOSOME 12Q; CHROMOSOME 17P; CHROMOSOME 5Q; CHROMOSOME 6Q; COHORT ANALYSIS; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; FEMALE; GENE LOCUS; GENETIC VARIABILITY; GENOME ANALYSIS; HEART LEFT ATRIUM; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE WALL; HEART SIZE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORPHOLOGICAL TRAIT; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC DYSFUNCTION; THICKNESS; TISSUE STRUCTURE; AORTA; CAUCASIAN; GENETIC ASSOCIATION; GENETICS; GENOTYPE; HEART ATRIUM; HEART VENTRICLE; HISTOLOGY; META ANALYSIS; MIDDLE AGED; ORGAN SIZE; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; AORTA; CARDIOVASCULAR DISEASES; ECHOCARDIOGRAPHY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HEART ATRIA; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; ORGAN SIZE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 67650103453     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2009.978-a     Document Type: Article

References (59)

1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Left ventricular mass and incidence of coronary heart disease in an elderly cohort: the Framingham Heart Study. Ann Intern Med. 1989;110(2):101-107.
2. Gardin JM, McClelland R, Kitzman D, et al. M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study).AmJ Cardiol. 2001; 87(9):1051-1057.
3. Bikkina M, Levy D, Evans JC, et al. Left ventricular mass and risk of stroke in an elderly cohort: the Framingham Heart Study. JAMA. 1994;272(1): 33-36.
4. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framing-ham Heart Study. N Engl J Med. 1990;322(22): 1561-1566.
5. Vasan RS, Larson MG, Levy D, Evans JC, Benjamin EJ. Distribution and categorization of echocardiographic measurements in relation to reference limits: the Framingham Heart Study: formulation of a height- and sex-specific classification and its prospective validation. Circulation. 1997;96(6):1863-1873.
6. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Levy D. Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med. 1997;336(19):1350-1355.
7. Wang TJ, Evans JC, Benjamin EJ, Levy D, LeRoy EC, Vasan RS. Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation. 2003;108(8):977-982.
8. Benjamin EJ, D'Agostino RB, Belanger AJ, Wolf PA, Levy D. Left atrial size and the risk of stroke and death: the Framingham Heart Study. Circulation. 1995; 92(4):835-841.
9. Gardin JM, Arnold AM, Polak J, Jackson S, Smith V, Gottdiener J. Usefulness of aortic root dimension in persons > or=65 years of age in predicting heart failure, stroke, cardiovascular mortality, all-cause mortality and acute myocardial infarction (from the Cardiovascular Health Study). Am J Cardiol. 2006; 97(2):270-275.
10. Arnett DK, Hong Y, Bella JN, et al; Hypertension Genetic Epidemiology Network. Sibling correlation of left ventricular mass and geometry in hypertensive African Americans and whites: the HyperGEN study. Am J Hypertens. 2001;14(12):1226-1230.
11. Bella JN, MacCluer JW, Roman MJ, et al. Heritability of left ventricular dimensions and mass in American Indians: the Strong Heart Study. J Hypertens. 2004; 22(2):281-286.
12. Bielen E, Fagard R, Amery A. The inheritance of left ventricular structure and function assessed by imaging and Doppler echocardiography. Am Heart J. 1991;121(6 pt 1):1743-1749.
13. Chien KL, Hsu HC, Su TC, Chen MF, Lee YT. Heritability and major gene effects on left ventricular mass in the Chinese population: a family study. BMC Cardiovasc Disord. 2006;6:37.
14. Harshfield GA, Grim CE, Hwang C, Savage DD, Anderson SJ. Genetic and environmental influences on echocardiographically determined left ventricular mass in black twins. Am J Hypertens. 1990;3(7): 538-543.
15. Palatini P, Krause L, Amerena J, et al. Genetic contribution to the variance in left ventricular mass: the Tecumseh Offspring Study. J Hypertens. 2001; 19(7):1217-1222.
16. Palatini P, Amerena J, Nesbitt S, et al. Heritability of left atrial size in the Tecumseh population. Eur J Clin Invest. 2002;32(7):467-471.
17. Post WS, Larson MG, Myers RH, Galderisi M, Levy D. Heritability of left ventricular mass: the Framingham Heart Study. Hypertension. 1997;30(5):1025-1028.
18. Bella JN, MacCluer JW, Roman MJ, et al. Genetic influences on aortic root size in American Indians: the Strong Heart Study. Arterioscler Thromb Vasc Biol. 2002;22(6):1008-1011.
19. Arnett DK, Devereux RB, Kitzman D, et al; Hypertension Genetic Epidemiology Network Study Group. Linkage of left ventricular contractility to chromosome 11 in humans: the HyperGEN Study. Hypertension. 2001;38(4):767-772.
20. Arnett DK, de las Fuentes L, Broeckel U. Genes for left ventricular hypertrophy. Curr Hypertens Rep. 2004;6(1):36-41.
21. Rankinen T, An P, Rice T, et al. Genomic scan for exercise blood pressure in the Health, Risk Factors, Exercise Training and Genetics (HERITAGE) Family Study. Hypertension. 2001;38(1):30-37.
22. Schunkert H, Hense HW, Holmer SR, et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med. 1994;330(23): 1634-1638.
23. Celentano A, Mancini FP, Crivaro M, et al. Cardiovascular risk factors, angiotensin-converting enzyme gene I/D polymorphism, and left ventricular mass in systemic hypertension. Am J Cardiol. 1999; 83(8):1196-1200.
24. Kuznetsova T, Staessen JA, Thijs L, et al; European Project on Genes in Hypertension (EPOGH) Investigators. Left Ventricular mass in relation to genetic variation in angiotensin II receptors, renin system genes, and sodium excretion. Circulation. 2004; 110(17):2644-2650.
25. Jamshidi Y, Montgomery HE, Hense HW, et al. Peroxisome proliferator-activated receptor alpha gene regulates left ventricular growth in response to exercise and hypertension. Circulation. 2002;105(8): 950-955.
26. Poch E, Gonzalez D, Gomez-Angelats E, et al. G-Protein beta(3) subunit gene variant and left ventricular hypertrophy in essential hypertension. Hypertension. 2000;35(1 pt 2):214-218.
27. Kupari M, Hautanen A, Lankinen L, et al. Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function. Circulation. 1998;97 (6):569-575.
28. Gomez-Angelats E, de la Sierra A, Enjuto M, et al. Lack of association between ACE gene polymorphism and left ventricular hypertrophy in essential hypertension. J Hum Hypertens. 2000;14(1):47-49.
29. Lindpaintner K, Lee M, Larson MG, et al. Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med. 1996;334(16):1023-1028.
30. Schunkert H, Hengstenberg C, Holmer SR, et al. Lack of association between a polymorphism of the aldosterone synthase gene and left ventricular structure. Circulation. 1999;99(17):2255-2260.
31. Sedlácek K, Fischer M, Erdmann J, et al. Relation of the G protein beta3-subunit polymorphism with left ventricle structure and function. Hypertension. 2002; 40(2):162-167.
32. Swan L, Birnie DH, Padmanabhan S, Inglis G, Connell JM, Hillis WS. The genetic determination of left ventricular mass in healthy adults. Eur Heart J. 2003; 24(6):577-582.
33. Manolio TA, Brooks LD, Collins FSA. HapMap harvest of insights into the genetics of common disease. J Clin Invest. 2008;118(5):1590-1605.
34. Psaty BM, O'Donnell CJ, Gudnason V, et al; CHARGE Consortium. Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: design of prospective meta-analyses of genome-wide association studies from five cohorts. Circ Cardiovasc Genet. 2009;2:73-80.
35. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991;1(3):263-276.
36. Hofman A, Breteler MM, van Duijn CM, et al. The Rotterdam Study: objectives and design update. Eur J Epidemiol. 2007;22(11):819-829.
37. Schunkert H, Doring A, Kuch B, et al; KORA Study Group. Cardiovascular phenotypes and functional parameters in the general population-results of the MONICA/KORA studies. Gesundheitswesen. 2005; 67(suppl 1):S74-S78.
38. Wichmann HE, Gieger C, Illig T; MONICA/ KORA Study Group. KORA-gen-resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen. 2005;67 (suppl 1):S26-S30.
39. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease in families: the Framingham offspring study. Am J Epidemiol. 1979;110(3):281-290.
40. John U, Greiner B, Hensel E, et al. Study of Health in Pomerania (SHIP): a health examination survey in an east German region: objectives and design. Soz Praventivmed. 2001;46(3):186-194.
41. Schmidt R, Lechner H, Fazekas F, et al. Assessment of cerebrovascular risk profiles in healthy persons: definition of research goals and the Austrian Stroke Prevention Study (ASPS). Neuroepidemiology. 1994;13(6):308-313.
42. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58(6): 1072-1083.
43. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57(6):450-458.
44. Vasan RS, Benjamin EJ, Larson MG, et al. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham Heart Study. JAMA. 2002;288(10): 1252-1259.
45. Li Y, Abecasis GR. Mach 1.0: rapid haplotype reconstruction and missing genotype inference. Am J Hum Genet. 2008;S79:2290. http://www.sph.umich. edu/csg/abecasis/MACH. Accessed June 14, 2009.
46. Marchini J, Howie B, Myers S, McVean G, Donnelly P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet. 2007;39(7):906-913.
47. Servin B, Stephens M. Imputation-based analysis of association studies: candidate regions and quantitative traits. PLoS Genet. 2007;3(7):e114.
48. Müller HH, Pahl R, Schäfer H. Including sampling and phenotyping costs into the optimization of two-stage designs for genomewide association studies. Gent Epidemiol. 2007;31(8): 844-852.
49. Bacanu SA, Devlin B, Roeder K. Association studies for quantitative traits in structured populations. Genet Epidemiol. 2002;22(1):78-93.
50. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447(7145):661-678.
51. Asahi M, Otsu K, Nakayama H, et al. Cardiac-specific overexpression of sarcolipin inhibits sarco (endo)plasmic reticulum Ca2+ATPase (SERCA2a) activity and impairs cardiac function in mice. Proc Natl Acad Sci U S A. 2004;101(25):9199-9204.
52. Haghighi K, Kolokathis F, Gramolini AO, et al. A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy. Proc Natl Acad Sci U S A. 2006; 103(5):1388-1393.
53. Snow BE, Erdmann N, Cruickshank J, et al. Functional conservation of the telomerase protein Est1p in humans. Curr Biol. 2003;13(8):698-704.
54. Cao Y, Li H, Mu FT, Ebisui O, Funder JW, Liu JP. Telomerase activation causes vascular smooth muscle cell proliferation in genetic hypertension. FASEB J. 2002; 16(1):96-98.
55. Xie Z, Moy LY, Sanada K, Zhou Y, Buchman JJ, Tsai LH. Cep120 and TACCs control interkinetic nuclear migration and the neural progenitor pool. Neuron. 2007;56(1):79-93.
56. Kazmierczak B, Dal CP, Wanschura S, et al. Cloning and molecular characterization of part of a new gene fused to HMGIC in mesenchymal tumors. Am J Pathol. 1998;152(2):431-435.
57. Weedon MN, Lettre G, Freathy RM, et al; Diabetes Genetics Initiative; Wellcome Trust Case Control Consortium; Wellcome Trust Case Control Consortium. A common variant of HMGA2 is associated with adult and childhood height in the general population. Nat Genet. 2007;39(10):1245-1250.
58. Zhou X, Benson KF, Ashar HR, Chada K. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature. 1995;376(6543):771-774.
59. Netherton SJ, Jimmo SL, Palmer D, et al. Altered phosphodiesterase 3-mediated camp hydrolysis contributes to a hypermotile phenotype in obese jcr: la-cp rat aortic vascular smooth muscle cells: implications for diabetes-associated cardiovascular disease. Diabetes. 2002;51(4):1194-1200.